Breaking News
Sort by:
Top Post
Moderna New Supply Agreement with Israel for 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a […]
Festival Republic Joins Government Pilot Programme with a Live Event to Trial the Safe Return of Fans
The Sefton Park Pilot, in partnership with Culture Liverpool, will further trial approaches to managing […]
Novavax to Participate in Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its […]
First Digital Vaccine Card Service VaxYes Converts 10,000 COVID Vaccine Cards Into Digital Vaccine Certificates
GoGetVax, the country’s first end-to-end COVID-19 vaccine technology platform, has successfully helped its first 10,000 users […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
Empatica First to Receive European CE Mark for Detecting Early Symptoms of COVID-19 Using Wearables
Digital biomarker and medical device company Empatica is awarded CE-certification for its Aura system to detect and […]
NHS Digital Selects Scandit’s Clinical Quality Computer Vision Technology to Digitise the Covid-Testing Process
Scandit, the leading technology platform for mobile computer vision and augmented reality (AR) solutions for […]
Antiparasitic Drug Could Prevent Coronavirus Lung Damage
A common antiparasitic drug could block lung damage in people with coronavirus, according to new […]
Healx Using Artificial Intelligence to Find Combination Drug Treatments for Covid-19
Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its […]
Twice Weekly Rapid Testing to be Available to Everyone in England
Everyone in England will be able to access free, regular, rapid coronavirus testing from 9 […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more